← All Bio Essence CORP filings

Bio Essence CORP 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

OQB
BIOE
Bio Essence CORP
8-K/A: Bio Essence Corp. Acquires MediFlow AI Software
Bio Essence Corp. has finalized the acquisition of MediFlow AI software from Zhituo Software Co., Limited, through an asset purchase agreement valued at $3.5 million.
OQB
BIOE
Bio Essence CORP
8-K: Bio Essence Corp. Restates Q1 2024 Financials Due to Lease Termination Error
Bio Essence Corp. has determined that its financial statements for the quarter ending March 31, 2024, can no longer be relied upon due to an error in accounting for a lease termination.
OQB
BIOE
Bio Essence CORP
8-K/A: Bio Essence Corp. Changes Auditors, Appoints Simon & Edward, LLP
Bio Essence Corp. has dismissed its previous independent accountant, Keith K. Zhen, CPA, and appointed Simon & Edward, LLP as its new principal accountant.
OQB
BIOE
Bio Essence CORP
8-K: Bio Essence Corp. Changes Independent Accountant, Appoints Simon & Edward, LLP
Bio Essence Corp. has dismissed its previous independent accountant, Keith K. Zhen, CPA, and appointed Simon & Edward, LLP as its new principal accountant, effective August 1, 2024.
OQB
BIOE
Bio Essence CORP
8-K: Bio Essence Corp. Announces Board Changes and Adopts Insider Trading Policy
Bio Essence Corp. has announced the resignation of two directors, the appointment of a new director, and the adoption of an insider trading policy.
OQB
BIOE
Bio Essence CORP
8-K: Bio Essence Corp. Sells Subsidiary for $400,000 in Cash Transaction
Bio Essence Corp. has sold its wholly-owned subsidiary, Bio Essence Herbal Essentials, Inc., to Health Up, Inc. for $400,000 in cash.